Gastric Cancer
📧 Sign up to get email alerts when something new happens for Gastric Cancer.
Sign up freeTop drugs studied for this disease
-
CLINICAL_TRIALS research · 2024-07-10Clinical Trial Update: Prospective Observational Cohort Study
This clinical trial update describes a prospective observational cohort study in patients with gastric cancer and liver metastases, which ha…
-
CLINICAL_TRIALS research · 2024-07-09Clinical Trial Update: Nivolumab Combined With SOX Used in the Perioperative Treatment [Phase 2]
Phase 2 clinical trial evaluating nivolumab plus the SOX regimen as perioperative treatment for gastric cancer. Recruitment is ongoing.
-
CLINICAL_TRIALS research · 2024-07-08Clinical Trial Update: Second-Line Chemotherapy With Ramucirumab +/- Paclitaxel in Elderly Advanced Gastric or Gastroesophageal Junction Cancer Patients [Phase 2]
Phase 2 study evaluating second-line ramucirumab with or without paclitaxel in elderly patients with advanced gastric or gastroesophageal ju…
-
CLINICAL_TRIALS research · 2024-07-08Clinical Trial Update: TQB2450 Plus Anlotinib Combined With Chemotherapy in the Treatment of Gastric or Gastroesophageal Junction Adenocarcinoma [NA]
Clinical trial update on a combination of TQB2450, Anlotinib, and chemotherapy for gastric cancer and esophagogastric junction adenocarcinom…
-
CLINICAL_TRIALS research · 2024-07-08Clinical Trial Update: Metronomic Capecitabine in Stage III Gastric Cancer [Phase 3]
A Phase 3 trial evaluating metronomic dosing of capecitabine for stage III gastric cancer is currently recruiting.
- Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.
-
CLINICAL_TRIALS research · 2024-07-08Clinical Trial Update: Clinical Trial Evaluating FOLFIRI + Durvalumab vs FOLFIRI + Durvalumab and Tremelimumab in Second-line Treatment of Patients With Advanced Gastric or Gastro-oesophageal Junction Adenocarcinoma [Phase 2]
A Phase 2 clinical trial is evaluating FOLFIRI plus Durvalumab versus FOLFIRI plus Durvalumab and Tremelimumab as second-line treatment for …
-
CLINICAL_TRIALS research · 2024-07-05Clinical Trial Update: Short Course Radiotherapy With Sequential Disitamab Vedotin Combined With S-1 and Sintilimab as Whole Course Neoadjuvant Therapy for HER2 Expressed Locally Progressive Gastric Cancer [Phase 2]
Phase 2 neoadjuvant trial evaluating short-course radiotherapy followed by disitamab vedotin with S-1 and sintilimab for HER2-expressed loca…
-
CLINICAL_TRIALS research · 2024-07-05Clinical Trial Update: Evaluation of Intra-operative Photographs for the Assessment of a Proper Lymphadenectomy in Minimally-invasive Gastrectomies for Gastric Cancer (PhotoNodes)
Clinical trial update describing a study (PhotoNodes) evaluating whether intra-operative photographs can assess the adequacy of lymphadenect…
-
CLINICAL_TRIALS research · 2024-07-05Clinical Trial Update: ERAS in Totally Laparoscopic Total Gastrectomy for Gastric Cancer [NA]
This clinical trial update notes a study on enhanced recovery after surgery (ERAS) in totally laparoscopic total gastrectomy for gastric can…
-
CLINICAL_TRIALS research · 2024-07-03Clinical Trial Update: A Real-world Study of Camrelizumab Alone or in Combination With Apatinib/Chemotherapy for Advanced Gastric Cancer
A real-world study is evaluating camrelizumab alone or in combination with apatinib or chemotherapy for advanced gastric cancer. The trial i…
-
CLINICAL_TRIALS research · 2024-06-27Clinical Trial Update: Machine Learning-driven Noninvasive Screening of Transcriptomics Liquid Biopsies for Early Diagnosis of Occult Peritoneal Metastases in Locally Advanced Gastric Cancer
This clinical trial update describes a study using machine learning-driven noninvasive transcriptomics screening to detect occult peritoneal…
-
CLINICAL_TRIALS research · 2024-06-25Clinical Trial Update: Triplex Checkpoint Inhibitors Therapy for Advanced Solid Tumors [Phase 1, Phase 2]
Clinical trial update for a triplex checkpoint inhibitor therapy evaluating safety and efficacy in advanced solid tumors, currently recruiti…
-
CLINICAL_TRIALS research · 2024-06-24Clinical Trial Update: Upfront Surgery Versus NeoAdjuvant Chemotherapy Followed by Surgery for Resectable Advanced Gastric Cancer: SNAC Study
This clinical trial compares upfront surgery with neoadjuvant chemotherapy followed by surgery for resectable advanced gastric cancer (SNAC …
-
CLINICAL_TRIALS research · 2024-06-24Clinical Trial Update: Study Evaluating the Efficacy of the myDIET Software Tool in the Nutritional Management of Patients With Localized and Resectable Gastric or Esogastric Junction Cancer. [Phase 2]
Phase 2 study evaluating the myDIET software tool for nutritional management in patients with localized, resectable gastric or gastroesophag…
-
CLINICAL_TRIALS research · 2024-06-21Clinical Trial Update: Prediction Model for Advanced Gastric Cancer in Elderly
This update describes a completed clinical trial evaluating a predictive model for advanced gastric cancer in elderly patients. The model is…
-
CLINICAL_TRIALS research · 2024-06-21Clinical Trial Update: Enhanced vs. Routine Follow-Up After Total Gastrectomy for Advanced Gastric Cancer: A Randomized Controlled Trial [NA]
A randomized controlled trial at Fudan University is evaluating enhanced versus routine follow-up after total gastrectomy for advanced gastr…
-
CLINICAL_TRIALS research · 2024-06-18Clinical Trial Update: A Real-World Study of Neoadjuvant/Conversion Therapy for Locally Advanced or Metastatic Gastric Cancer
This clinical trial update describes a real-world study evaluating neoadjuvant/conversion therapy for locally advanced or metastatic gastric…
-
CLINICAL_TRIALS research · 2024-06-13Clinical Trial Update: Adjuvant TRastuzumab Deruxtecan for HER2-positive Gastroesophageal Cancer With Persistence of miNImal Residual Disease [Phase 2]
ClinicalTrials.gov listing for a Phase 2 adjuvant trial of trastuzumab deruxtecan in HER2-positive gastric cancer with persistent minimal re…
-
CLINICAL_TRIALS research · 2024-06-12Clinical Trial Update: Conversion Therapy of Sintilimab in Combination With Fruquintinib and Chemotherapy Versus Sintilimab and Chemotherpay in Stage IV Gastric Cancer [Phase 2]
A Phase 2 clinical trial is evaluating whether adding Fruquintinib to Sintilimab and chemotherapy improves outcomes versus Sintilimab and ch…
-
CLINICAL_TRIALS research · 2024-06-11Clinical Trial Update: Predicting Gastric Cancer Response to Chemo With Multimodal AI Model
A clinical study is exploring a multimodal AI model to predict how gastric cancer responds to chemotherapy; the trial is currently recruitin…
-
CLINICAL_TRIALS research · 2024-06-11Clinical Trial Update: Neoadjuvant Immunotherapy Plus Chemotherapy in Borrmann Type 4 and Large Type 3 Gastric Cancer [Phase 2]
This is a Phase 2 clinical trial evaluating neoadjuvant immunotherapy plus chemotherapy for Borrmann type 4 and large type 3 gastric cancer.…
-
CLINICAL_TRIALS research · 2024-06-07Clinical Trial Update: Perioperative Surufatinib Plus Sintilimab Combined With Chemotherapy in Gastric/Gastroesophageal Junction Adenocarcinoma [Phase 2]
Phase 2 clinical trial update evaluating perioperative surufatinib plus sintilimab with chemotherapy for gastric cancer and gastroesophageal…
-
CLINICAL_TRIALS research · 2024-06-07Clinical Trial Update: GlobalSurg 3: Quality and Outcomes in Global Cancer Surgery
GlobalSurg 3 is a multinational trial on quality and outcomes in global cancer surgery; this update indicates the study has completed and in…
-
CLINICAL_TRIALS research · 2024-06-06Clinical Trial Update: Toripalimab Plus FLOT in Locally Advanced Gastric Cancer [Phase 2]
Phase 2 clinical trial evaluating toripalimab in combination with the FLOT chemotherapy regimen for locally advanced gastric cancer is curre…
-
CLINICAL_TRIALS research · 2024-06-03Clinical Trial Update: Adjuvant Treatment With Serplulimab，Trastuzumab and SOX in the HER-2 Positive GC/GEJC [Phase 2]
A Phase 2 clinical trial update evaluating adjuvant therapy with serplulimab, trastuzumab, and the SOX regimen (S-1 plus oxaliplatin) for HE…